Posted by Michael Wonder on 09 Nov 2023
MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss
8 November 2023 - For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
The MHRA has today authorised via a national application route, a new indication for the diabetes medicine, Mounjaro (tirzepatide), for weight loss and weight management in adults aged 18 and over.
